These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8389178)

  • 41. Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma.
    Cherqui D
    J Hepatobiliary Pancreat Surg; 1998; 5(1):35-40. PubMed ID: 9683752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Indication and results of liver transplantation].
    Pichlmayr R; Brölsch C; Neuhaus P; Wonigeit K
    Z Gastroenterol Verh; 1983 Apr; 18():70-4. PubMed ID: 6192611
    [No Abstract]   [Full Text] [Related]  

  • 43. Ligation of a branch of the portal vein for carcinoma of the liver.
    Honjo I; Suzuki T; Ozawa K; Takasan H; Kitamura O
    Am J Surg; 1975 Sep; 130(3):296-302. PubMed ID: 170837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sorafenib use in the transplant setting.
    Castelli G; Burra P; Giacomin A; Vitale A; Senzolo M; Cillo U; Farinati F
    Liver Transpl; 2014 Sep; 20(9):1021-8. PubMed ID: 24809799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of the surgical treatment of malignant liver tumors].
    Zhuravlev VA; Korepanov VI; Vasil'ev PN
    Vopr Onkol; 1972; 18(10):36-42. PubMed ID: 4351070
    [No Abstract]   [Full Text] [Related]  

  • 46. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma.
    Söderdahl G; Bäckman L; Isoniemi H; Cahlin C; Höckerstedt K; Broomé U; Mäkisalo H; Friman S; Ericzon BG
    Transpl Int; 2006 Apr; 19(4):288-94. PubMed ID: 16573544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretransplant chemotherapy in pediatric hepatocellular carcinoma.
    Broughan TA; Esquivel CO; Vogt DP; Griffin GC; Norris DG
    J Pediatr Surg; 1994 Oct; 29(10):1319-22. PubMed ID: 7807316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence.
    Reyes JD; Carr B; Dvorchik I; Kocoshis S; Jaffe R; Gerber D; Mazariegos GV; Bueno J; Selby R
    J Pediatr; 2000 Jun; 136(6):795-804. PubMed ID: 10839879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Liver neoplasms in children].
    Coronado Pérez H; Angulo Hernández O
    Bol Med Hosp Infant Mex; 1981; 38(5):723-40. PubMed ID: 6275866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation for malignant tumours.
    Ringe B; Pichlmayr R
    Baillieres Clin Gastroenterol; 1989 Oct; 3(4):787-97. PubMed ID: 2561919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hepatocellular carcinoma.
    Dutta U
    J Gastroenterol Hepatol; 2000 Aug; 15(8):822-4. PubMed ID: 11022821
    [No Abstract]   [Full Text] [Related]  

  • 52. [Departmental review of surgical cases in the last 17 years: Liver neoplasms].
    Shimada M; Shirabe T; Tanaka S; Maeda T; Yamashita Y; Rikimaru T; Tsujita H; Maehara S; Harimoto N; Ikeda Y; Ashidate H; Utsunomiya T; Esaki T; Furuta T; Sonoda T; Matsumata T; Takenaka K; Kanematsu T
    Fukuoka Igaku Zasshi; 2002 Mar; 93(3 Suppl):16-9. PubMed ID: 11989235
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatocellular carcinoma: the search for innovative adjuvant therapies.
    Yen Y; Zhou W
    Oncology (Williston Park); 2009 Dec; 23(14):1291, 1294. PubMed ID: 20120843
    [No Abstract]   [Full Text] [Related]  

  • 54. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
    Saab S; McTigue M; Finn RS; Busuttil RW
    Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
    Volk M; Marrero JA
    Gastroenterology; 2008 May; 134(5):1612-4. PubMed ID: 18471530
    [No Abstract]   [Full Text] [Related]  

  • 56. Getting a handle on posttransplant recurrence of HCC.
    de Vera ME
    Oncology (Williston Park); 2009 Dec; 23(14):1287, 1291. PubMed ID: 20120842
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatocellular carcinoma: sorafenib before liver transplantation?
    Braillon A
    Hepatology; 2010 Jun; 51(6):2232-3. PubMed ID: 20041410
    [No Abstract]   [Full Text] [Related]  

  • 58. Subrenal capsule assay using liver cancer specimens obtained by fine needle biopsy.
    Fukushima H
    Kurume Med J; 1991; 38(3):181-6. PubMed ID: 1664008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinico-pathological features and surgical management of primary epithelial hepatic malignancies.
    Heuschen UA; Hofmann WJ; Otto HF; Schlag P; Herfarth C
    Eur J Surg Oncol; 1990 Aug; 16(4):332-45. PubMed ID: 1696213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.
    Fahrner R; Dondorf F; Ardelt M; Dittmar Y; Settmacher U; Rauchfuß F
    World J Gastroenterol; 2015 Nov; 21(42):12071-82. PubMed ID: 26576092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.